BioLine RX Ltd (NASDAQ:BLRX)
| 1.94 Data as of Jul 24 |  -0.03 / -1.52%Today’s Change | 1.79 Today|||52-Week Range 3.34 | -30.96% Year-to-Date |
Latest BLRX News | Press Releases
No recent news for BioLine RX Ltd.
Today’s Trading
| Previous close | 1.97 |
| Today’s open | 1.95 |
| Day’s range | -- - -- |
| Volume | 34,519 |
| Average volume (3 months) | 93,516 |
| Market cap | $66.2M |
| Dividend yield | -- |
Data as of 07/24/2014
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CBRXColumbia Laboratorie... | +0.15 | +2.42% |
| OGXIOncoGenex Pharmaceut... | +0.08 | +2.58% |
| MSTXMast Therapeutics In... | -0.02 | -2.85% |
| HSKAHeska Corp | -0.01 | -0.09% |
Data as of 07/24/2014
Financials
| Next reporting date | August 26, 2014 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters --, -- |
Forecasts
.
